Wall Street analysts predict that Walgreens Boots Alliance Inc (NASDAQ:WBA) will report $34.53 billion in sales for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Walgreens Boots Alliance’s earnings, with the highest sales estimate coming in at $35.14 billion and the lowest estimate coming in at $33.60 billion. Walgreens Boots Alliance posted sales of $34.33 billion during the same quarter last year, which would indicate a positive year over year growth rate of 0.6%. The business is expected to announce its next quarterly earnings results before the market opens on Thursday, June 27th.
On average, analysts expect that Walgreens Boots Alliance will report full-year sales of $136.74 billion for the current fiscal year, with estimates ranging from $134.38 billion to $137.58 billion. For the next fiscal year, analysts expect that the firm will report sales of $139.34 billion, with estimates ranging from $136.90 billion to $141.98 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that follow Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 EPS for the quarter, missing analysts’ consensus estimates of $1.70 by ($0.06). The business had revenue of $34.53 billion for the quarter, compared to the consensus estimate of $34.57 billion. Walgreens Boots Alliance had a return on equity of 22.00% and a net margin of 3.77%. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.73 EPS.
In other Walgreens Boots Alliance news, COO Ornella Barra bought 18,000 shares of the stock in a transaction on Wednesday, April 3rd. The stock was purchased at an average price of $54.56 per share, with a total value of $982,080.00. Following the acquisition, the chief operating officer now owns 26,425 shares of the company’s stock, valued at $1,441,748. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Marco Patrick Anthony Pagni sold 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $53.05, for a total transaction of $1,061,000.00. Following the sale, the chief accounting officer now directly owns 435,811 shares of the company’s stock, valued at approximately $23,119,773.55. The disclosure for this sale can be found here. Company insiders own 15.73% of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in WBA. Oregon Public Employees Retirement Fund boosted its position in shares of Walgreens Boots Alliance by 12,422.1% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 34,807,507 shares of the pharmacy operator’s stock worth $509,000 after purchasing an additional 34,529,539 shares in the last quarter. Norges Bank bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $589,781,000. Boston Partners lifted its position in Walgreens Boots Alliance by 3,449.3% in the 4th quarter. Boston Partners now owns 3,973,944 shares of the pharmacy operator’s stock valued at $271,540,000 after acquiring an additional 3,861,981 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in Walgreens Boots Alliance by 263.4% in the 1st quarter. The Manufacturers Life Insurance Company now owns 3,306,439 shares of the pharmacy operator’s stock valued at $209,198,000 after acquiring an additional 2,396,640 shares in the last quarter. Finally, APG Asset Management N.V. lifted its position in Walgreens Boots Alliance by 66.2% in the 4th quarter. APG Asset Management N.V. now owns 3,740,281 shares of the pharmacy operator’s stock valued at $223,569,000 after acquiring an additional 1,489,401 shares in the last quarter. 61.60% of the stock is owned by hedge funds and other institutional investors.
WBA traded down $0.32 during midday trading on Tuesday, reaching $52.57. 3,230,056 shares of the company’s stock were exchanged, compared to its average volume of 4,368,899. The stock has a market cap of $48.06 billion, a price-to-earnings ratio of 8.60, a P/E/G ratio of 1.08 and a beta of 0.77. The company has a quick ratio of 0.38, a current ratio of 0.78 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance has a one year low of $49.31 and a one year high of $86.31.
The business also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Monday, May 20th were issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.35%. The ex-dividend date of this dividend was Friday, May 17th. Walgreens Boots Alliance’s dividend payout ratio is currently 29.24%.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.